Why Co-Diagnostics Stock Is Soaring 15.5% Higher Today

Shares of Co-Diagnostics (NASDAQ: CODX) were soaring 15.5% higher as of 11:22 a.m. EDT on Thursday. The big jump came after the company announced that its COVID-19 test technology has been validated for use on saliva samples.

Anyone who saw President Trump's press conference around a month ago after he was tested for COVID-19 heard the president say "there was nothing pleasant" about the test. Initial COVID-19 testing was done using nasal swabs. And they're not pleasant.

Image source: Getty Images.

Continue reading

Source Fool.com